AI is revolutionising healthcare strategies

In the dynamic landscape of healthcare, the continuous evolution of drug development and patient engagement necessitates ongoing innovation. Recently, GLP-1 drugs have garnered considerable attention for their revolutionary impact on treating various medical conditions, including weight loss. To explore this phenomenon further, Scott Crae, Co-Founder of Talking Medicines, hosted a session that delved into insights derived from unstructured conversational data.

Justin Wyman, Chief Revenue Officer at Socialgist, highlighted the immense potential of public online conversations aggregated by Socialgist, totalling an impressive 35 billion discussions annually. These conversations, spanning platforms from message boards to blogs and review sites, provide candid and unfiltered insights into individuals’ health perceptions and experiences, contrasting with traditional polling methods or mainstream social platforms.

Roma English Owen, Data Intelligence and Analytics Manager at Talking Medicines, explained the meticulous process of handling this vast data. Talking Medicines ensures the accuracy and relevance of the data, removing any personal identifiers. Through rigorous curation, the data is optimised for analysis, resulting in what Owen calls “curated data,” a refined dataset ready for insightful exploration.

Central to this data-driven approach is Drug-GPT, a proprietary AI model developed by Talking Medicines. By processing curated data, Drug-GPT provides healthcare professionals with actionable intelligence from unstructured conversational data, enhancing productivity and return on investment. Its user-friendly natural language interface eliminates training barriers, making invaluable insights accessible and fostering more effective strategies.

The session underscored the significant potential of combining advanced AI technologies with unstructured conversational data to shape the future of healthcare. By understanding the intricacies of healthcare discourse surrounding GLP-1 drugs and other advancements, stakeholders can navigate the complex healthcare landscape with greater confidence and efficacy. Drug-GPT captures the lived experiences of the GLP-1 drugs revolution, supporting data-driven decision-making and ushering in a new era of informed healthcare strategies.

In conclusion, the discussion highlighted the transformative power of analysing unstructured conversational data in healthcare, particularly regarding GLP-1 drugs. By leveraging advanced AI models like Drug-GPT and curated data from platforms like Socialgist, stakeholders gain invaluable insights, driving productivity and informed healthcare strategies. For strategists seeking clarity amidst complexity, Drug-GPT is more than a tool; it is an essential partner in transforming healthcare marketing strategies into informed, data-driven powerhouses.

Tern plc (LON:TERN) backs exciting, high growth IoT innovators in Europe. They provide support and create a genuinely collaborative environment for talented, well-motivated teams. The Talking Medicines mission is to be the World’s Gold Standard for Patient Intelligence by Medicine.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Tern plc

More articles like this

Tern plc

Empowering rare disease communities through AI

Rare disease communities encounter a range of challenges that go far beyond just patient care, many of which are frequently overlooked in broader health strategies. With more than 7,000 rare diseases affecting relatively small and diverse

Tern plc

How IoT automation is transforming industry

The integration of the Internet of Things (IoT) is reshaping the way industries operate, particularly through innovations like smart manufacturing, predictive maintenance, and remote monitoring. With these advancements, industries can streamline processes, improve productivity, and enhance

Tern plc

Understanding business valuation methods

Knowing how to value your business is crucial when planning to sell or raise capital. Both buyers and investors will require insight into the business’s current financial standing and its projected performance. A variety of methods

Tern plc

Harnessing ‘Data for Good’

The importance of data in addressing global challenges has grown significantly as we near 2025. The “Data for Good” movement continues to evolve, driven by advances in technology, increased global collaboration, and a rising focus on

Tern plc

How IoT automation is transforming industrial operations

The integration of IoT into industrial automation is reshaping the landscape of industries by improving efficiency, reducing costs, and enhancing safety. The ability to connect physical devices to the internet has revolutionised sectors such as manufacturing,

Tern plc

Strategic approaches for successful IIoT implementation

Recent research highlights a significant challenge in the realm of IoT projects, with 74% of companies finding their initiatives unsuccessful. This is often due to extended timeframes, lack of expertise, and insufficient understanding of IoT requirements.

Tern plc

Unlocking the potential of AI and IIoT in modern manufacturing

Advanced technology in manufacturing often conjures images of high-tech environments like the automotive industry or robotic warehouses. However, with the increasing accessibility of artificial intelligence (AI) solutions, many more manufacturing operations can now benefit from these

Tern plc

FundamentalVR elevates surgical training with advanced Stylus integration

FundamentalVR, a global leader in immersive surgical training, has recently integrated Logitech’s MX Ink MR Stylus into its state-of-the-art VR platform. This development significantly boosts the realism and precision of VR-based surgical simulations, offering healthcare professionals

Tern plc

Unlocking the potential of IIoT for future success

As with any new technological advancement, the journey from initial excitement to widespread adoption often follows a familiar trajectory. The Internet of Things (IoT), which connects countless devices in our daily lives, is no exception. According

Tern plc

Transforming surgical training through Virtual Reality innovation

FundamentalVR is at the forefront of revolutionising surgical training through immersive virtual reality (VR) technologies. Under the leadership of Chief Technology Officer Vicky Smalley, the company is dedicated to advancing human capability in surgery and medicine.

Tern plc

Securing your business in the age of IoT connectivity

Protecting your business in the digital age with a solid IoT security framework is essential. The rise of interconnected devices has transformed how businesses function, offering numerous advantages like enhanced efficiency and streamlined operations. However, this

Tern plc

The Wyld Connect AT452 Satellite Tracker

The Wyld Connect AT452 Satellite Tracker offers an extensive solution for location-based tracking, harnessing low earth orbiting satellites to provide worldwide network coverage. Following successful trials in South America, Wyld is set to roll out this

Tern plc

Enhancing healthcare communication with Drug-GPT insights

Understanding the nuanced perspectives of both patients and healthcare professionals (HCPs) is crucial for developing effective and empathetic communication strategies. A recent case study demonstrates how Drug-GPT’s Audience Analyzer enabled a healthcare advertising agency to achieve

Tern plc

Optimising brand planning in healthcare marketing with Drug-GPT

As we approach the start of brand planning season, Healthcare Marketing Strategists face immense pressure to develop effective, data-driven strategies. The necessity for rapid and precise data analysis is critical, and Drug-GPT emerges as an essential